IP Library › Granted Patent US 10,927,052
Granted Patent B2
US 10,927,052 · App. 16/811,327 · Granted Feb 23, 2021

Decene oligomers

Inventors: Robert C. Coffin (Kingwood, TX); Steven M. Bischof (Humble, TX); Lauren M. Kattchee (Houston, TX); Kenneth M. Lassen (Bartlesville, OK); Jason L. Kreider (Bartlesville, OK)
Assignee: Chevron Phillips Chemical Company LP
C07C2/08C07C2/06C07C2/12C07C2/26C07C2/88C10M105/04C10M107/10C07C2527/125C07C2527/1213C07C2531/02C10M2205/0285C10N2020/071C10N2060/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,927,052
App. No.
16/811,327
Granted
Feb 23, 2021
Kind
B2
Abstract

A composition comprising olefin oligomers of one or more olefin monomers, the olefin monomers comprising a branched C 10 olefin monomer comprising i) 3-propyl-1-heptene, ii) 4-ethyl-1-octene, iii) 5-methyl-1-nonene, or iv) any combination thereof. A composition comprising substantially hydrogenated olefin oligomers, wherein the olefin oligomers are oligomers of one or more olefin monomers, the olefin monomers comprising a branched C 10 olefin monomer comprising i) 3-propyl-1-heptene, ii) 4-ethyl-1-octene, iii) 5-methyl-1-nonene, or iv) any combination thereof. A process comprising a) contacting 1) a catalyst system and 2) a monomer feedstock comprising a branched C 10 olefin monomer comprising i) 3-propyl-1-heptene, ii) 4-ethyl-1-octene, iii) 5-methyl-1-nonene, or iv) any combination thereof in a reaction zone; and b) forming olefin oligomers.

Claims (12)

1. A composition comprising olefin oligomers of one or more olefin monomers, the olefin monomers comprising branched C 10 olefin monomers comprising i) 3-propyl-1-heptene, ii) 4-ethyl-1-octene, and iii) 5-methyl-1-nonene; wherein the branched C 10 olefin monomers have a molar ratio of 5-methyl-1-nonene to 3-propyl-1-heptene of at least 1.6:1 and/or a molar ratio of 5-methyl-1-nonene to 4-ethyl-1-octene of at least 1.6:1.

2. The composition of claim 1 , wherein the branched C 10 olefin monomers comprises i) at least 10 mol % 3-propyl-1-heptene, ii) at least 7 mol % 4-ethyl-1-octene, iii) at least 24 mol % 5-methyl-1-nonene, and iv) at least 3 mol % 2-butyl-1-hexene.

3. The composition of claim 1 , wherein the olefin monomers further comprise 1) a linear internal C 10 olefin monomer selected from 4-decene, 5-decene, or any combination thereof and/or 2) linear internal C 14 olefin monomers, branched C 14 olefin monomers, or any combination thereof.

4. The composition of claim 1 , wherein the olefin monomers further comprise less than or equal to 75 mol % of at least one C 6 to C 18 normal alpha olefin monomer.

5. The composition of claim 4 , wherein the C 6 to C 18 normal alpha olefin monomer comprises 1-octene, 1-decene, 1-dodecene, or any combination thereof.

6. The composition of claim 1 , wherein the olefin monomers comprise 1) at least 80 mol % branched C 10 olefin monomers, the branched C 10 olefin monomers comprising i) from 10 mol % to 32 mol % 3-propyl-1-heptene, ii) from 7 mol % to 25 mol % 4-ethyl-1-octene, iii) from 24 mol % to 52 mol % 5-methyl-1-nonene, and iv) from 3 mol % to 20 mol % 2-butyl-1-hexene; and 2) less than 10 mole % C 6 to C 18 normal alpha olefin monomer.

7. A composition comprising substantially hydrogenated olefin oligomers, wherein the olefin oligomers are oligomers of one or more olefin monomers, the olefin monomers comprising branched C 10 olefin monomers comprising i) 3-propyl-1-heptene, ii) 4-ethyl-1-octene, and iii) 5-methyl-1-nonene; wherein the branched C 10 olefin monomers have a molar ratio of 5-methyl-1-nonene to 3-propyl-1-heptene of at least 1.6:1 and/or a molar ratio of 5-methyl-1-nonene to 4-ethyl-1-octene of at least 1.6:1.

8. The composition of claim 7 , wherein the branched C 10 olefin monomers comprises i) at least 10 mol % 3-propyl-1-heptene, ii) at least 7 mol % 4-ethyl-1-octene, iii) at least 24 mol % 5-methyl-1-nonene, and iv) at least 3 mol % 2-butyl-1-hexene.

9. The composition of claim 7 , wherein the olefin monomers further comprise 1) a linear internal C 10 olefin monomer selected from 4-decene, 5-decene, or any combination thereof and/or 2) linear internal C 14 olefin monomers, branched C 14 olefin monomers, or any combination thereof.

10. The composition of claim 7 , wherein the olefin monomers further comprise less than or equal to 75 mol % of at least one C 6 to C 18 normal alpha olefin monomer.

11. The composition of claim 10 , wherein the C 6 to C 18 normal alpha olefin monomer comprises 1-octene, 1-decene, 1-dodecene, or any combination thereof.

12. The composition of claim 7 , wherein the olefin monomers comprise 1) at least 80 mol % branched C 10 olefin monomers, the branched C 10 olefin monomers comprising i) from 10 mol % to 32 mol % 3-propyl-1-heptene, ii) from 7 mol % to 25 mol % 4-ethyl-1-octene, iii) from 24 mol % to 52 mol % 5-methyl-1-nonene, and iv) from 3 mol % to 20 mol % 2-butyl-1-hexene; and 2) less than 10 mol % normal alpha olefin monomer.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 6, 2020
From: COFFIN, ROBERT C.; BISCHOF, STEVEN M.; KATTCHEE, LAUREN M.; LASSEN, KENNETH M.; KREIDER, JASON L.
To: CHEVRON PHILLIPS CHEMICAL COMPANY LP
Reel/Frame 052119/0489 →
Continuity (2)
Continuation 15207712 · Jul 12, 2016
Related Publication 20200207682A1 · Jul 2, 2020
Cited By (3)
US 12,528,999 US 12,540,287 US 12,618,016